Skip to main content

and
  1. Article

    Open Access

    Significance of men’s health in long-term survivors of allogeneic stem cell transplantation

    Laila Schneidewind, Thomas Neumann, Nandette Peters in Bone Marrow Transplantation (2022)

  2. Article

    Open Access

    Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia

    To investigate the efficacy and toxicities of CPX-351 outside a clinical trial, we analyzed 188 patients (median age 65 years, range 26–80) treated for therapy-related acute myeloid leukemia (t-AML, 29%) or AM...

    Christina Rautenberg, Friedrich Stölzel, Christoph Röllig in Blood Cancer Journal (2021)

  3. No Access

    Article

    Ibrutinib as a salvage therapy after allogeneic HCT for chronic lymphocytic leukemia

    The purpose of our study is to provide information on safety and efficacy of ibrutinib as salvage treatment after allo-HSCT for CLL. A total of 56 patients were included, 36 (64%) males; median age at transpla...

    Mauricette Michallet, Peter Dreger, Mohamad Sobh in Bone Marrow Transplantation (2020)

  4. No Access

    Article

    Treatment of relapsed AML and MDS after allogeneic stem cell transplantation with decitabine and DLI—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group

    In contrast to the evidence regarding azacitidine (Aza), there is limited knowledge about the combination of decitabine (DAC) and donor lymphocyte infusions as salvage therapy for relapse after allogeneic stem...

    Thomas Schroeder, Christina Rautenberg, William Krüger in Annals of Hematology (2018)

  5. No Access

    Article

    Nationwide survey of BK polyomavirus associated hemorrhagic cystitis in adult allogeneic stem cell transplantation among haematologists and urologists

    There are no epidemiological data on BK virus associated hemorrhagic cystitis (BKHC) in adult allogeneic stem cell transplantation in Germany available and associations with clinical conditions like GvHD are c...

    Laila Schneidewind, Thomas Neumann, Jennifer Kranz, Florian Knoll in Annals of Hematology (2017)

  6. Article

    Open Access

    Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016

    Infectious complications after allogeneic haematopoietic stem cell transplantation (allo-HCT) remain a clinical challenge. This is a guideline provided by the AGIHO (Infectious Diseases Working Group) of the D...

    Andrew J. Ullmann, Martin Schmidt-Hieber, Hartmut Bertz in Annals of Hematology (2016)

  7. Article

    Open Access

    Treatment of invasive fungal infections in cancer patients—updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    The Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO) here presents its updated recommendations for the treatment of documented fungal infections. Invasive funga...

    Sabine Mousset, Dieter Buchheidt, Werner Heinz, Markus Ruhnke in Annals of Hematology (2014)

  8. No Access

    Article

    Antimicrobial therapy of febrile complications after high-dose chemotherapy and autologous hematopoietic stem cell transplantation—guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    More than 18,000 autolgous transplantation were performed in Europe in the year 2009. It as a routine procedure in experienced centres. Even if there is a low mortality rate, infections are a major issue after...

    Florian Weissinger, Holger W. Auner, Hartmut Bertz in Annals of Hematology (2012)

  9. No Access

    Article

    Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

    Invasive fungal infections are a main cause of morbidity and mortality in cancer patients undergoing intensive chemotherapy regimens. Early antifungal treatment is mandatory to improve survival. Today, a numbe...

    Angelika Böhme, Markus Ruhnke, Dieter Buchheidt, Oliver A. Cornely in Annals of Hematology (2009)

  10. No Access

    Article

    Erdheim–Chester disease with hemophagocytosis

    Christoph Busemann, Bianca Kallinich, Günther Schwesinger in Annals of Hematology (2007)

  11. Article

    Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies

    The risk of infection after allogeneic stem cell transplantation is determined by the underlying disease, the intensity of previous treatments and complications that may have occurred during that time, but abo...

    Hermann Einsele, Hartmut Bertz, Jörg Beyer, Michael G. Kiehl in Annals of Hematology (2003)

  12. No Access

    Article

    Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors

    Morbidity and mortality in patients with malignancies, especially leukemia and lymphoma, are increased by invasive fungal infections. Since diagnosis of invasive fungal infection is often delayed, antifungal p...

    Oliver A. Cornely, Angelika Böhme, Dieter Buchheidt in Annals of Hematology (2003)

  13. No Access

    Article

    Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM)

    We investigated toxicity and efficacy of in vivo T-cell depletion with anti-thymocyte globulin (ATG) as part of an intensified myeloablative conditioning regimen followed by allogeneic stem cell transplantation i...

    Nicolaus Kröger, Hermann Einsele, Daniel Wolff in Bone Marrow Transplantation (2003)

  14. No Access

    Article

    Anti-Thymocyte-Globulin as part of the preparative regimen prevents graft failure and severe Graft versus Host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors

    To reduce the incidence of GvHD and the rate of graft failure in unrelated stem cell transplantation, we incorporate anti-thymocyte globulin in the preparative regimen in 98 patients with hematological or inhe...

    Nicolaus Kröger, Tatjana Zabelina, William Krüger, Helmut Renges in Annals of Hematology (2001)

  15. No Access

    Article

    Tumour cell detection in G-CSF mobilised stem cell harvests of patients with breast cancer

    Peripheral blood stem cells were mobilised with G-CSF from steady-state haemopoiesis after previous anthracyclin-containing standard dose chemotherapy in patients with high-risk breast cancer. 48 samples were ...

    William Krüger, Florian Tögel, Nicolaus Kröger, Sabine Rössing in Medical Oncology (1999)

  16. No Access

    Article

    Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients

    A two-step reverse-transcriptase-based polymerase chain reaction (PCR) with nested primer pairs was developed to amplify sensitive and specific cytokeratin-19 (CK-19) mRNA sequences from human breast cancer ce...

    William Krüger, Cordula Krzizanowski in Journal of Cancer Research and Clinical On… (1996)